Company: TCMD
Filing Date: 2025-03-28
Form Type: DEF 14A
Source: 0001558370-25-003924
Chunk: 17

Company: TACTILE SYSTEMS TECHNOLOGY INC
Filing Date: 2025-03-28
Form: DEF 14A
Chunk 17
---
 the concerns that influenced the vote. We currently hold our say-on-pay vote every year, so the next advisory vote on the compensation of our named executive officers will occur at our 2026 Annual Meeting of Stockholders, subject to the Board’s consideration of the outcome of the advisory vote regarding the frequency of future say-on-pay votes, which is included as Proposal 4 for the Annual Meeting.

| ​ | ​                                                                                                                              |
| √ | The Board of Directors recommends that stockholders vote FOR the approval of the compensation of our named executive officers. |

| ​  | ​                                |
| 30 | Tactile Systems Technology, Inc. |

| ​                                                                                             |
| PROPOSAL 4: ADVISORY VOTE on the frequency of future advisory votes on executive compensation |

We are providing our stockholders the opportunity to cast an advisory (non-binding) vote on the frequency of future advisory votes to approve the compensation of our named executive officers. This proposal gives our stockholders the opportunity to express their views as to whether future say-on-pay votes should occur every one, two or three years. Because your vote is advisory, it will not be binding on the Board of Directors. However, the Board will carefully consider the outcome of the frequency vote and other communications from stockholders when making future decisions regarding the frequency of say-on-pay votes. After careful consideration, the Board of Directors believes that submitting the advisory vote on executive compensation to stockholders on an annual basis continues to be appropriate.

| ​ | ​                                                                                                                                        |
| √ | The Board of Directors recommends that stockholders vote for a frequency of ONE YEAR for future advisory votes on executive compensation |

| ​                    |  ​ |
| 2025 Proxy Statement | 31 |

Executive Compensation

EXECUTIVE COMPENSATION Compensation Discussion and Analysis This section discusses the material components of the executive compensation program for our named executive officers identified below. For 2024, our named executive officers were:

| ● | Sheri L. Dodd, Chief Executive Officer; |

| ● | Elaine M. Birkemeyer, Chief Financial Officer; |

| ● | Kristie T. Burns, Senior Vice President, Marketing and Clinical Affairs; |

Effective July 1, 2024, Ms. Dodd was appointed our Chief Executive Officer, replacing Mr. Reuvers, who had announced his retirement as Chief Executive Officer. Mr. Reuvers did not receive any severance or similar payments or benefits as a result of his retirement. Mr. Reuvers continued to be